Quest Diagnostics Health Trends

Quest Diagnostics Health Trends, based on analysis of Quest Diagnostics laboratory and health data, are designed to inform healthcare professionals, patients, and policymakers about the status of the nation’s health.

Quest Diagnostics is the world’s leading provider of diagnostic information services. We manage the largest database of clinical laboratory data, based on more than 48 billion laboratory test results. To provide novel public health insights, our team of experts, comprised of physicians, clinical scientists, and data scientists, publish original research in peer-reviewed medical journals and as white papers, present at conferences, and work with public health agencies, academics, and healthcare organizations. Please contact us at Please contact us at HealthTrends@QuestDiagnostics.com for additional information.

Browse our library for a series of articles, reports, and videos from leading medical experts, statisticians, and data scientists at Quest Diagnostics.

Abstract Clinical Education Article Clinical Education Webinar Health Trends™ Report Peer-Reviewed Study Research Findings Article Research Findings Chart Research Findings Map Testing Guide

 

Type Title Category Year
Cardiovascular
Clinical
Education Webinar

Improving Cardiovascular Health for Women: The Essentials for Every OB/GYN Practice Dr. Gersh discusses how to assess cardiovascular risk for women patients within an OB/GYN practice and how to utilize key lab tests, beyond standard lipid panels, to gain a deeper insight...

Cardiovascular Watch >
2019 +
Research
Findings Article

National Assessment of Warfarin Anticoagulation Therapy for Stroke Prevention in Atrial Fibrillation Approximately 1 in 2 patients with atrial fibrillation do not optimally reduce their risk of stroke or bleeding when treated with the most widely prescribed...

Cardiovascular View >
2014 +
Research
Findings Article

Blood Cholesterol Trends 2001–2011 in the United States: Analysis of 105 Million Patient Records Decades of declines in LDL cholesterol blood levels, a key marker of death risk from heart disease, abruptly ended in 2008, and may have stalled since, according to a multi-year, national study...

Cardiovascular View >
2013 +
Research
Findings Article

Cardiovascular health and the well-woman visit: providing more comprehensive care Despite advances in gender-specific medicine, women are still less likely to receive guideline-recommended diagnostic testing and therapies, including cardiovascular screening...

Cardiovascular View >
2018 +
Research
Findings Article

Heart Failure Prevention, Diagnosis, and Management The role of natriuretic peptides and other biomarkers in the prevention, diagnosis, and management of heart failure. Update from the American College of Cardiology/American Heart Association/Heart Failure Society of America (ACC/AHA/HFSA) recommendations for the use of biomarkers in heart failure...

Cardiovascular Download >
2019 +
Abstract

A lost decade: no meaningful changes in low-density lipoprotein cholesterol in the United States, 2008-2017: insights from a national reference laboratory A retrospective analysis of 126 million LDL-C test results determined that the average LDL-C blood level remained relatively stable for both men and women, regardless of age group...

Cardiovascular View >
2019 +
Cardiovascular: Diabetes
Health Trends Report

Diabetes Report: US Patients Improved Diabetes Control Over 5-Year Period Quest Diagnostics Health Trends Diabetes Report is based on 14.3 million test results from 2001–2005 from the nation’s largest database of clinical lab results...

Diabetes View >
2006 +
Peer-Reviewed Study

Surge in Newly Identified Diabetes Among Medicaid Patients in 2014 Within Medicaid Expansion States Under the Affordable Care Act Dr. Harvey W. Kaufman, senior medical director at Quest Diagnostics, examines the impact of US Medicaid expansion on the number of Medicaid patients with newly identified diabetes...

Diabetes View >
2015 +
Peer-Reviewed Study

Closing the Gap on Health Inequality Dr. Harvey W. Kaufman, senior medical director at Quest Diagnostics, reports that people in states that expanded Medicaid under the Affordable Care Act (ACA) are far more likely to be newly diagnosed with diabetes than those in states that elected not to expand the program. Based on a study published in Diabetes Care...

Diabetes View >
2016 +
Research
Findings Article

Insulin Resistance and Diabetes A discussion about insulin resistance and its relationship to prediabetes, type 2 DM, and other medical conditions ranging from cardiovascular to gynecologic. Also discussed are risk factors for insulin resistance, methods for diagnosis, and how lifestyle changes can treat insulin resistance and subsequently reduce the risk for developing diabetes...

Diabetes Download >
2016 +
Infectious Disease/Inflammatory: Allergies
Health Trends Report

Allergies Across America™: The Largest Study of Allergy Testing in the United States In Allergies Across America, Quest Diagnostics provides results of the largest analysis of allergy testing on patients in the United States who are under medical evaluation for symptoms associated with allergies...

Allergies Download >
2011 +
Testing
Guide

Allergens by the numbers: Testing for whole allergen proteins can help you better diagnose allergies/sensitizations and prepare personalized management plans. Testing for whole allergen proteins can help you better diagnose allergies/sensitizations and prepare personalized management plans. Use this testing guide, complete with test names and codes, to select an allergy testing regimen for your patients...

Allergies Download >
2017 +
Infectious Disease/Inflammatory: Arthritis
Clinical
Education Webinar

The Appropriate Use of Diagnostic Testing in the Management of Rheumatoid Arthritis Martin J. Bergman, MD, Clinical Associate Professor of Medicine, Drexel University College of Medicine, Philadephia, PAMD, discusses the seriousness of a diagnosis of rheumatoid arthritis for patients who are afflicted and the appropriate use and limitations of laboratory testing in the diagnosis and monitoring for rheumatoid disease...

Arthritis Watch >
2012 +
Abstract

Serum 14-3-3η is a Novel Marker that Complements Current Serological Measurements to Enhance Detection of Patients with Rheumatoid Arthritis Researchers from Quest Diagnostics (NYSE: DGX) and other institutions found that elevated blood-serum levels of the 14- 3-3eta protein outperformed conventional antibody-serum testing, including rheumatoid factor (RF) and anti-citrullinated peptide antibodies (ACPA, also known as antibodies to cyclic citrullinated peptides or CCP), for the identification of RA...

Arthritis View >
2014 +
Infectious Disease/Inflammatory: Autoimmune Disease
Clinical
Education Webinar

14-3-3eta Protein: A New Direction in the Early Diagnosis of Rheumatoid Arthritis Dr. Walter Maksymowych, Scientist, Alberta Heritage Foundation for Medical Research, Consultant Rheumatologist and Professor of Medicine, University of Alberta, Edmonton, discusses the diagnostic and prognostic value of the 14-3-3eta protein in rheumatoid arthritis and the clinical relevance of a new assay that measures this biomarker...

Autoimmune Disease Watch >
2013 +
Clinical
Education Webinar

ANA – The Misunderstood Lab Test Bergman, Martin J., MD, Clinical Associate Professor of Medicine, Drexel University College of Medicine, Philadephia, PA discusses the primary screen and testing for autoimmune diseases...

Autoimmune Disease Watch >
2016 +
Research
Findings Chart

Autoantibody Prevalence in Autoimmune Diseases Physician Reference Guide: Autoantibody disease prevalence, autoantibody, and diagnostic criteria...

Autoimmune Disease Download >
2016 +
Infectious Disease/Inflammatory: Infectious Disease
Clinical
Education Article

A New Algorithm for HIV Laboratory Testing Bernard M. Branson, MD, Associate Director for Laboratory Diagnostics, Office of the Director, Division of HIV/AIDS Prevention, Centers for Disease Control and Prevention discusses the rationale for developing the new algorithm. He explains how it will enable earlier detection of HIV infection and reduce the number of indeterminate results, leading to improved patient management and long-term outcomes...

Infectious Disease View >
2014 +
Clinical
Education Article

Chikungunya: A Growing Public Health Concern for the United States Dr. Holly Batterman, Medical Director, Focus Diagnostics, a Quest Diagnostics subsidiary, discusses the epidemiology and clinical features of chikungunya infection, reviews its diagnostic challenges and discusses the implications of the outbreak for health care providers in the United States...

Infectious Disease View >
2014 +
Peer-Reviewed Study

Geographic Disparities in Access to Syringe Services Programs Among Young Persons with Hepatitis C Virus Infection in the United States 80% of 29382 young persons currently infected with hepatitis C virus lived >10 miles from a syringe services program, as reported by Dr. Harvey W. Kaufman, senior medical director at Quest Diagnostics, Randall Young, MA, Division of Toxicology and Human Health Sciences, Agency for Toxic Substances and Disease Registry, CDC...

Infectious Disease View >
2017 +
Clinical Education Webinar

H pylori: Gaps in Care Ali M. Amir, MD, Staff Gastroenterologist, Assistant Professor of Medicine, George Washington University, Washington, DC discusses important information to medical professionals on the appropriate diagnosis and treatment for early onset of H pylori, why testing prior to prescribing a proton pump inhibitor is essential for optimal patient care and helps attendees understand the importance of H pylori eradication....

Infectious Disease Watch >
2014 +
Health Trends™ Report

H1N1 Testing in America: After the Pandemic’s Peak Decline in testing demand, positivity rates suggest the end of pandemic’s peak in 2009...

Infectious Disease Download >
2010 +
Health Trends™ Report

H1N1 Testing in America: H1N1 the Dominant Flu of 2009-2010 Findings suggest the H1N1 virus has “crowded out” other flu viruses, to be virtually the only influenza virus circulating in the US since it was first identified in April 2009...

Infectious Disease Download >
2010 +
Research
Finding Article

Hepatitis A surveillance using commercial laboratory data Laboratory data from Quest Diagnostics and Laboratory Corporation of America was used to monitor trends in HAV infections over time and identify geographic and demographic characteristics of HAV case clusters for the propose of targeting interventions...

Infectious Disease View >
2018 +
Peer-Reviewed Study

Trends in Hepatitis B infection and immunity among women of childbearing age in the United States A retrospective analysis of HBV status among women of childbearing age nationally and by state was conducted utilizing the Quest Diagnostics database. Rates of HBV in women born before and after implementation of universal HBV vaccination recommendations were determined...

Infectious Disease View >
2019 +
Research
Findings Article

Hepatitis C—Diagnosis and Cure With about 71 million people infected worldwide, chronic hepatitis C virus (HCV) infection is a global health problem. HCV infection increases the risk of liver fibrosis, cirrhosis, and liver cancer, and is responsible for almost 400,000 deaths annually...

Infectious Disease Download >
2018 +
Peer-Reviewed Study

Laboratory Blood-Based Testing for Lyme Disease at a National Reference Laboratory: A 7-Year Experience (2010-2016) Positive tests were observed in all 50 states and the District of Columbia. New York had the most positive tests, whereas Connecticut had the highest positivity rate when normalized to state populations. Some states with historically low rates of LD (eg, Texas, Florida, and California) showed significant increases in testing and positivity rates over time...

Infectious Disease View >
2016 +
Peer-Reviewed Study

Laboratory blood-based testing for non-Lyme Disease tick-borne infections at a national reference laboratory: a 7-year experience (2010-2016) Testing and positivity for most non-Lyme disease tick-borne diseases (NLTBI) increased dramatically from 2010 through 2016, generally exceeding the number of positive cases reported by the Centers for Disease Control and Prevention...

Infectious Disease Watch >
2019 +
Abstract

Measuring trends in hepatitis C testing with commercial laboratory data Using the 2 largest commercial laboratory data sources nationally, we estimated the annual rates of hepatitis C testing among individuals who were recommended to be tested (i.e., baby boomer cohort born between 1945 and 1965) by the CDC and United States Preventive Services Task Force...

Infectious Disease View >
2019 +
Research
Findings Article

Preventing HIV: PrEP and Laboratory Testing Discussion on PrEP, as well as the role of laboratory testing before and during PrEP. How (PrEP) treatment regimen reduces the risk of HIV infection in uninfected individuals who are at high risk of contracting HIV...

Infectious Disease Download >
2018 +
Peer-Reviewed Study

Q fever: an under-reported reportable communicable disease The objective of this study was to provide real world clinical laboratory based data to supplement Centers for Disease Control and Prevention (CDC) reporting of Q fever. Dr. Harvey W. Kaufman, senior medical director at Quest Diagnostics...

Infectious Disease View >
2019 +
Health Trends™ Report

Health Trends™: Lyme Disease—Quest data reveal more cases in more places In this Quest Diagnostics Health Trends™ report, Quest identifies rates of Lyme disease based on 6 million deidentified results of immunoglobulin (IgG) laboratory tests...

Infectious Disease Download >
2018 +
Peer-Reviewed Study

The Burden of Hepatitis C Infection-Related Liver Fibrosis in the United States A large proportion of persons infected with HCV do not receive care and only half of those with advanced fibrosis or cirrhosis are evaluated for treatment. Xiaohau Huang, Strategic Initiatives and Data Analytics, Quest Diagnostics, West Norriton, PA...

Infectious Disease View >
2016 +
Testing
Guide

TBBloodTesting.com The CDC and other medical organizations prefer interferon-gamma release assays (IGRAs) for certain patient populations—here’s why you should, too...

Infectious Disease View >
2019 +
Clinical Education Webinar

Tick-Borne Illness: An Expert Panel Discussion on Disease States and Diagnostic Testing Options Hema Kapoor, MD, D (ABMM), SM, Director, Medical Science Liaison, infectious Diseases and Immunology leads a panel discussion on tick-borne diseases with some of the leading infectious disease experts from Quest Diagnostics...

Infectious Disease Watch >
2018 +
Abstract

Trends in HIV-1 drug resistance mutations from a US reference laboratory: 2006-2017 Trends in resistance to antiretroviral drugs for HIV-1 may inform clinical support and drug development. Drug resistance mutations (DRM) trends for nucleoside reverse transcriptase inhibitor (NRTI), nonnucleoside reverse transcriptase inhibitor (NNRTI), protease inhibitor (PI), and integrase strand transfer inhibitor (INSTI) were evaluated...

Infectious Disease View >
2019 +
Peer-Reviewed Study

Trends in Laboratory Rotavirus Detection: 2003 to 2014 Dr. Harvey W. Kaufman, senior medical director at Quest Diagnostics, assessed the impact of rotavirus vaccination at national and state levels by evaluating the change in rotavirus antigen detection after vaccination licensure...

Infectious Disease View >
2016 +
Clinical Education Webinar

Zika virus and other mosquito-borne infections in 2016 John A.D. Leake, MD, MPH, Medical Director, Infectious Diseases, discusses the epidemiology of Zika virus, including co-circulating viruses transmitted by Aedes aegypti mosquito, the clinical features of Zika virus and special issues in pregnancy...

Infectious Disease Watch >
2016 +
Peer-Reviewed Study

Increasing number of metabolic co-morbidities are associated with higher risk of advanced fibrosis in patients with non-alcoholic steatohepatitis The presence of fibrosis is the strongest predictor of mortality and liver-related complications among patients with non-alcoholic steatohepatitis (NASH). More accurately understanding the prevalence and predictors of advanced fibrosis among NASH patients is important to guide healthcare resource planning so that adequate preventative care and interventions can be effectively targeted to those NASH patients at greatest risk of liver-related complications...

Infectious Disease View >
2019 +
Neurology
Clinical
Education Webinar

Breakthroughs in Alzheimer’s Disease Assessment: Quantitation of CSF Beta Amyloid 40 & 42 Nigel J. Clarke, PhD, Senior Science Director for Mass Spectrometry and Automation, discusses the advantages in assessing Alzheimer’s disease by measurement of amyloid beta 42/40 ratio, describes an improved LC-MS/MS approach...

Neurology Watch >
2017 +
Clinical
Education Webinar

Diagnostic Biomarkers in Alzheimer’s Disease Lealani Mae Acosta, MD, MPH, Assistant Professor of Neurology Department of Neurology, Vanderbilt University Medical Center, describes the clinical diagnosis of Alzheimer’s disease (AD), discusses pathological changes and outlines the currently available AD biomarkers...

Neurology Watch >
2017 +
Research
Findings Article

New ways of thinking about Alzheimer’s disease Evaluating AD biomarkers with this new methodology may help clarify the relative likelihood of AD, which could lead to better patient management...

Neurology Download >
2019 +
Research
Findings Article

Testing Brain Health How to objectively test for brain health—arguments for and against universal screening, testing asymptomatic seniors...

Neurology Download >
2019 +
Research
Findings Article

Early Assessment of Brain Health Data on brain health, cognition and screening for cognitive impairment point to the benefits of early assessment of dementia. However, there is lack of agreement on whether asymptomatic elderly individuals should be screened. Several arguments have been made...

Neurology Download >
2018 +
Testing
Guide

Dementia Dementia is a condition which includes a wide range of symptoms linked to declining memory, thinking skills, trouble with reasoning and judgment, changes in personality confusion...

Neurology Download >
2014 +
Oncology
Clinical
Education Webinar

Which of your patients should be offered genetic testing for cancer risk in 2019? Ellen Matloff, MS, CGC, President and CEO of My Gene Counsel, discusses which current and past patients are candidates for cancer genetic testing and explains why sharing genetic testing data is critical to clinical research and the future of patient care...

Oncology Watch >
2019 +
Research
Findings Article

Colorectal Cancer Screening: New Guideline Recommends Starting at a Younger Age ACS CRC Screening Guidelines and the 2018 ACS screening recommendations and options for persons with an average risk of developing CRC...

Oncology Download >
2019 +
Research
Findings Article

Cervical Cancer Screening Research points to the benefits of co-testing for women 30 to 65 years of age, and reviews screening options for cervical cancer in other age groups...

Oncology Download >
2019 +
Prescription Drug Monitoring
Health Trends™ Report

Health Trends™ Drug Misuse in America 2019—Physician Perspectives and Diagnostic Insights into the Evolving Drug Crisis The annual report from Quest Diagnostics presents findings from analysis of more than 4.4 million de-identified aggregated clinical drug monitoring tests performed by Quest Diagnostics for patients from all 50 states and District of Columbia from 2011 through 2018. The report also incorporates findings from a survey conducted by The Harris Poll, commissioned by Quest Diagnostics and Center of Addiction, of 500 primary care physicians in the United States...

Prescription Drug Monitoring Download >
2019 +
Clinical
Education Article

Tackling the polypharmacy problem in chronic care management Polypharmacy, the use of multiple medications, is a particular concern for older patients and their clinicians; the greater the number of medications prescribed, the greater the likelihood that issues will be present...

Prescription Drug Monitoring View >
2018 +
Peer-Reviewed Study

Drug misuse and Hepatitis C virus infection profiles for three generations of patients being monitored for prescription drug adherence A retrospective study looked at prescription drug consistency and HCV patient test results to quantify the relationship between illicit/prescription drug misuse and HCV infection in 3 population generations: baby boomers (born 1945-1965, inclusive), pre-baby boomers, and post-baby boomers...

Prescription Drug Monitoring View >
2019 +
Health Trends™ Report

Drug Testing Index™ 2017: A comprehensive analysis of workplace drug use trends Cocaine, marijuana, and methamphetamine use is up broadly among United States workforce across multiple specimen types and testing populations...

Prescription Drug Monitoring Download >
2017 +
Health Trends™ Report

Drug Testing Index™ 2018: A comprehensive analysis of workplace drug use trends The Quest Diagnostics Drug Testing Index (DTI) reveals insights into patterns of drug use among the American workforce. Published annually for 30 years, the Drug Testing Index examines positivity rates for workplace drugs tested by the company on behalf of employers...

Prescription Drug Monitoring Download >
2018 +
Health Trends™ Report

Health Trends™: Drug Misuse in America 2018—Diagnostic Insights from Clinical Drug Monitoring into the Opioid Epidemic In this report, we provide findings from analysis of more than 3.9 million de-identified, aggregated clinical drug monitoring tests performed by Quest Diagnostics for patients in all 50 states and D.C....

Prescription Drug Monitoring Download >
2018 +
Health Trends™ Report

Health Trends™ Drug Misuse in America 2017—Diagnostic Insights into the Growing Drug Epidemic The growth in opioid abuse has been called an epidemic, and for good reason: Between 2014 and 2015, overdose drug deaths in the United States increased by 11%, from 47,055 to 52,404, primarily driven by heroin and synthetic opioids...

Prescription Drug Monitoring Download >
2017 +
Health Trends™ Report

Health Trends™ Drug Misuse in America 2016—Diagnostic Insights into the Continuing Drug Epidemic Battle In this report, Quest medical and scientific experts analyzed a national sample of 3,143,739 de-identified patient test results performed over a recent five-year period...

Prescription Drug Monitoring Download >
2016 +
Health Trends™ Report

Infographic: Prescription Medication Misuse Studies show that the majority of patients taking prescription medications are misusing them. Get the facts here...

Prescription Drug Monitoring Download >
2017 +
Health Trends™ Report

Health Trends™ Drug Misuse in America 2015—Diagnostic Insights into the Continuing Drug Epidemic Battle Our 2015 report builds on our prior research and continues to confirm high rates of inconsistent test results among patients prescribed pain medications, spanning all age ranges and both genders.

Prescription Drug Monitoring Download >
2015 +
Health Trends™ Report

Prescription Drug Misuse in America: Diagnostic Insights into Managing the Drug Epidemic The abuse of prescription painkillers and narcotics has grown into a bona fide public health crisis, affecting virtually every state, city and small town in the United States. Nearly half of the roughly 40,000 drug overdose deaths...

Prescription Drug Monitoring Download >
2014 +
Health Trends™ Report

Prescription Drug Misuse in America 2013—A report on marijuana and prescription drugs This Quest Diagnostics Health Trends report focuses on the role of marijuana in the use, and misuse, of prescription and other illicit drugs, based on de-identified results of patients tested by Quest Diagnostics in 2011 and 2012.

Prescription Drug Monitoring Download >
2013 +
Peer-Reviewed Study

Concurrent Use of Opioids and Benzodiazepines: Evaluation of Prescription Drug Monitoring by a United States Laboratory Since 2000, the rate of opioid deaths in the United States has tripled. Drug overdose deaths rose to the highest level ever recorded in 2015 and may have risen since...

Prescription Drug Monitoring View >
2017 +
Research
Findings Map

Drug Testing Index™: Overall Positivity Rate in 2018 This interactive map shows urine drug test positivity in the United States. Search by zip code for a comprehensive analysis of workforce drug use trends...

Prescription Drug Monitoring View >
2018 +
Research
Findings Article

Prescription Drug Monitoring Physicians must know what drugs are in a patient’s system, prescribed or not. A discussion on the origins of the opioid epidemic and the benefits of comprehensively monitoring prescription drug use with urine testing...

Prescription Drug Monitoring Download >
2018 +
Research
Findings Article

Workforce Drug Positivity Rises by Double-Digits in Almost One-Third of US Industry Sectors Examined, According to New Quest Diagnostics Analysis Drug use by the US workforce increased each year according to data from more than 10 million urine drug test results performed by Quest Diagnostics...

Prescription Drug Monitoring Download >
2018 +
Testing
Guide

Reasons for drug testing Drug testing can help to improve employee morale and productivity while decreasing absenteeism, accidents, downtime, turnover, and theft. Understanding when to test is directly linked to which drug testing solution your organization should select. This resource page explores...

Prescription Drug Monitoring View >
2019 +
Testing
Guide

Powering Efficient Behavioral Health Care Services Streamlining behavioral health care decisions through comprehensive and efficient drug monitoring...

Prescription Drug Monitoring Download >
2016 +
Testing
Guide

Battling an unprecedented epidemic Battling an unprecedented epidemic, this guide provides helpful insights into protecting your patients from medication misuse...

Prescription Drug Monitoring Download >
2016 +
Testing
Guide

Prescription Drug Monitoring Reference Guide In-depth reference guide for prescription drug monitoring, tests, and services...

Prescription Drug Monitoring Download >
2018 +
Testing
Guide

Prescription Drug Monitoring and Toxicity: ICD-10-CM Resource Guide Guidelines for International Classification of Diseases, 10th Edition, Clinical Modification/Procedure Coding System...

Prescription Drug Monitoring Download >
2017 +
Women’s Health
Clinical
Education Webinar

Improving Cardiovascular Health for Women: The Essentials for Every OB/GYN Practice Dr. Gersh discusses how to assess cardiovascular (CV) risk for women patients within an OB/GYN practice and learn how to utilize key laboratory tests, beyond standard lipid panels, to gain a deeper insight into the cardiovascular risk of your patients...

Women’s Health Watch >
2019 +
Peer-Reviewed Study

Prenatal cell-free DNA screening for fetal aneuploidy in pregnant women at average or high risk: Results from a large US clinical laboratory The American College of Medical Genetics and Genomics recommends informing all pregnant women that noninvasive cell-free DNA (cfDNA) prenatal screening is the most sensitive screening option for detecting. Carrie Guy, Quest Diagnostics Nichols Institute, San Juan Capistrano, CA...

Women’s Health View >
2019 +
Peer-Reviewed Study

Comparison of cervical cancer screening results among 256,648 women in multiple clinical practices In the United States, concurrent human papillomavirus (HPV) and Papanicolaou (Pap) testing (co-testing) is recommended for cervical cancer screening among women ages 30 to 65 years...

Women’s Health View >
2016 +
Peer-Reviewed Study

Gaps in Diabetes Screening During Pregnancy and Postpartum A study published in Obstetrics and Gynecology reports on screening rates and prevalence of gestational diabetes mellitus (GDM) and the prevalence of postpartum diabetes. In a large, national sample of pregnant women, Dr. Harvey W. Kaufman, senior medical director at Quest Diagnostics...

Women’s Health View >
2011 +
Peer-Reviewed Study

National Status of Testing for Hypothyroidism during Pregnancy and Postpartum The aim of this study was to estimate thyroid testing rate and positivity during pregnancy and postpartum, including testing and positivity rates. Jon M. Nakamoto, Laboratory Medical Director, Quest Diagnostics Nichols Institute, San Juan Capistrano, CA, Associate Professor of Pediatrics and Endocrinology, University of California...

Women’s Health View >
2012 +
Peer-Reviewed Study

Neighborhood Socioeconomic Status in Relation to Serum Biomarkers in the Black Women’s Health Study Lower neighborhood socioeconomic status (SES) is associated with higher cardiovascular disease (CVD) risk...

Women’s Health View >
2016 +
Peer-Reviewed Study

Predicted 25-hydroxyvitamin D in relation to incidence of breast cancer in a large cohort of African American women Vitamin D deficiency, which has been linked to an increased risk of colorectal cancer, is particularly common among African Americans. Previous studies of vitamin D status and breast cancer risk, mostly conducted in white women...

Women’s Health View >
2016 +
Research
Findings Article

Recurrent Pregnancy Loss: Finding Hope Many different medical conditions can cause infertility in both men and women. Some of these conditions may result in an inability to conceive, while others may cause recurrent pregnancy loss. Approximately 15% to 25% of recognized pregnancies end in a miscarriage...

Women’s Health View >
2019 +
Peer-Reviewed Study

Hepatitis C Virus in Women of Childbearing Age, Pregnant Women, and Children In 2015, a total of 0.38% (n=14,417) of live births were delivered by hepatitis C virus–infected women. Births delivered by hepatitis C virus–infected women, compared with births overall, occurred more often in women who were aged 20–29 years (60.7% vs 50.9%); white...

Women’s Health View >
2018 +
Research Findings Article

Cervical Cancer Screening This guide discusses the benefits of co-testing for women 30 to 65 years of age, and reviews screening options for cervical cancer in other age groups...

Women’s Health Download >
2019 +
Clinical
Education Article

Hepatitis C—The Primary Care Physician’s Role in Reducing the Epidemic’s Impact Paul E. Sax, MD, Clinical Director of the Division of Infectious Diseases, Brigham and Women’s Hospital, Professor of Medicine, Harvard Medical School, Boston MA, discusses the critical role of primary care physicians in identifying those infected with HCV and reducing the burden of chronic liver disease through timely intervention...

Women’s Health View >
2013 +

For more information or if you have any questions, please contact HealthTrends@QuestDiagnostics.com